APOC3 and diabetes mellitus: The insulin-resistant study participants did not differ from the non-insulin-resistant group in terms of age, years of diabetes duration, HbA1c level, and renal and hepatic performance as well as concentrations of NT-proBNP, GDF-15, or APOC3 (Table 2).